Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.

ABSTRACT:

SUBMITTER: Yang S 

PROVIDER: S-EPMC7990482 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature